Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 50 of 147 publications.
Demarteau N, Standaert B, Earnshaw S. Mathematical programming modeling to optimise allocation of healthcare interventions. In: Ethgen O, Staginnus U, editors. The future of health economics. New York: Routledge; 2016.
Jackson TK. Pharmacovigilance and Risk Management. In: Fundamentals of US regulatory affairs. 9th ed. Rockville: MD. Regulatory Affairs Professionals Society (RAPS); 2015. p.231-40. Available at: http://www.raps.org/Regulatory-Focus/RAPS-Latest/2015/08/10/22788/New-Fundamentals-of-US-Regulatory-Affairs-Book-Now-Available/. Accessed June 3, 2016.
Hollis K, Gilsenan A. Design and implementation of surveys to assess patient and healthcare provider understanding of risks and safe use conditions. In: Andrews EB, Moore N, editors. Mann's pharmacovigilance. 3rd ed. Chichester, West Sussex, UK: UK. Wiley-Blackwell; 2014.doi: 10.1002/9781118820186.ch49.
Brown DS, Poulos C, Johnson FR, Chamiec-Case L, Messonnier ML. Adolescent girls' preferences for HPV vaccines: A discrete choice experiment. In: Glenn C. Blomquist, Kristian Bolin (ed.), editors. Preference measurement in health. Bingley: United Kingdom. Emerald Group Publishing Limited; 2014. p.93-121. doi: 10.1108/S0731-2199_2014_0000024002.
West SL, Ritchey ME, Poole C. Validity of pharmacoepidemiologic drug and diagnosis data. In: Strom B, Kimmel S, Hennesey S, editors. Textbook of pharmacoepidemiology. 2nd ed. New York: NY. Wiley-Blackwell; 2013. p.205-27.
Haase D, Piorr A, Schwarz N, Rickebusch S, Kroll F, van Delden H, Zuin A, Taylor T, Boeri M, Zasada I, Lavalle C, Vanhout R, Sarretta A, Meuller F, Rounsevell M, Bell S. Tools for modelling and assessing peri-urban land use futures. In: Peri-urban futures: scenarios and models for land use change in Europe. Berlin: Germany. Springer-Verlag Berlin Heidelberg; 2013. p.69-90. doi: 10.1007/978-3-642-30529-0.
Cainzos-Achirica M, Bueno D, Bas D, Poveda P, Recasens L. A woman with brain hemorrhage, atrial fibrilation and high embolic risk. In: Gonzalo Baron Esquivias, Ignacio Fernandez Lozano, Inmaculada Roldan Rabadan, Miguel Camafort Babkowski, John F. Arenillas Lara, Laura thorny Manzano, Javier Garcia Alegria, Juan Carlos Lopez Fernandez, editors. Clinical cases in brain vascular disease and anticoagulation 2012-2013. Madrid: Spain. Luzan 5; 2013.
Fernandez A, Cainzos M, Bueno D, Perez A, Recasens L. A 26-year-old Philippine male with a stroke. In: Gonzalo Baron Esquivias, Ignacio Fernandez Lozano, Inmaculada Roldan Rabadan, Miguel Camafort Babkowski, John F. Arenillas Lara, Laura thorny Manzano, Javier Garcia Alegria, Juan Carlos Lopez Fernandez, editors. Clinical cases in brain vascular disease and anticoagulation 2012-2013. Madrid: Spain. Luzan 5; 2013.
Buck PM, Kumar S, Wang X, Agrawal NJ, Trout BL, Singh SK. Computational methods to predict therapeutic protein aggregation. In: Voynov V, Caravella JA, editors. Therapeutic proteins. Totowa: NJ. Humana Press; 2012. p.425-51. doi: 10.1007/978-1-61779-921-1_26.
West SL, Ritchey ME, Poole C. Validity of pharmacoepidemiologic drug and diagnosis data. In: Strom B, Kimmel S, Hennesey S, editors. Pharmacoepidemiology. 5th ed. New York: NY. Wiley-Blackwell; 2012. p.757-98.

Pages